Ardian, CVC, Verdane eye investments in women’s health; Momentum in pathology services drives exit by Exellere, GHO
Highlighting how various subsegments of the women’s health market have caught the eye of private equity firms such as Ardian, CVC and Verdane; a look at Excellere Partners and GHO Capital Partners’ $950 million agreement to sell a pathology services company to Agilent Therapeutics; new appointments announced by Vistria.
13 March 2026•4 mins read
